wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33556988-2AEFF550-4226-4582-9C32-D7C37CC1C287
Q33556988-2AEFF550-4226-4582-9C32-D7C37CC1C287
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33556988-2AEFF550-4226-4582-9C32-D7C37CC1C287
A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors.
P2860
Q33556988-2AEFF550-4226-4582-9C32-D7C37CC1C287
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33556988-2AEFF550-4226-4582-9C32-D7C37CC1C287
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f3c55cf12cf3a67ba87021969f2434814dafbd0
P2860
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain